Cristiane “Cyborg” Justino is possibly in hot water with USADA.
According to a statement released by the UFC on Thursday, the 31-year-old Brazilian was notified of a potential Anti-Doping Policy violation stemming from an out-of-competition drug test administered on December 5. So far, no penalty has been imposed and her case will undergo further investigation.
The full statement issued by the UFC can be read below:
The UFC organization was formally notified today that the U.S. Anti-Doping Agency (USADA) has informed Cristiane “Cyborg” Justino of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on December 5, 2016.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed.
Consistent with all previous potential anti-doping violations, additional information or UFC statements will be provided at the appropriate time as the process moves forward.
“Cyborg”, who has tested positive for performance-enhancing drugs back in 2011, explained on her Facebook page that the substance she tested positive for was a diuretic called Spironolactone. According to the post, the drug was prescribed to her by her doctor as part of her recovery process from a brutal weight cut in her last fight. She is currently in the process of applying for a retroactive therapeutic use exemption from USADA to continue her treatment.